Nanotechnology has emerged as one of the world?s most promising new technologies. Due to the rapid growth of the nanotechnology field, heath risk assessment for both workers and consumers is warranted. Engineered nanomaterials (ENM) are widely used in electronics, healthcare and consumer goods. Due to the wide variety of ENM, making sweeping assessments of their toxicity is difficult. Bioactive ENM have been demonstrated to cause alveolar macrophages to release the pro-inflammatory cytokine interleukin-1beta (IL-1?). Some ENM have been linked to lysosome membrane permeability (LMP) as evident by the release of cathepsin B from lysosomes. Cytosolic cathepsin B initiates NLRP3 inflammasome assembly, which in turn results in the activation caspase-1, followed by the cleavage of pro- IL-1? to its active form. What is also known is that ENM are internalized by macrophages in phagosomes. However, the mechanism causing ENM initiated LMP is still unclear. It has been suggested that increased fluidity or lipid disorder in the lysosome membrane increases the chance of LMP. This proposal will investigate the mechanism of ENM initiated LMP. A well-characterized set of ENM will be used to determine different physical and chemical differences that affect LMP. Model membrane systems, nanodiscs and liposomes, and mouse alveolar macrophages will also be utilized. To assess changes in membrane fluidity, the order/disorder of the phospholipids, solvatochromic fluorescence probes and time-resolved fluorescent spectroscopy/microscopy will be used to measure fluorescence lifetime, fluorescence anisotropy and fluorescence correlation. The amount of LMP will also be measured using a digitonin extraction method to measure the activity of cytosolic lysosome enzymes without permeabilizing lysosomes. The purposed questions of this study are of great importance and will be answered in this proposal.

Public Health Relevance

/Relevance This study will examine the mechanism of ENM-induced lysosome membrane permeability. Furthermore, this study will assess the effect of ENM on lipid membrane structure and lysosomal membrane fluidity. Finally, ENM induced LMP will be measured along with indicators of inflammation and toxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32ES027324-02
Application #
9329272
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Nadadur, Srikanth
Project Start
2016-09-01
Project End
2019-08-31
Budget Start
2017-09-01
Budget End
2018-08-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Montana
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
010379790
City
Missoula
State
MT
Country
United States
Zip Code
59812